I am grateful for the invitation to attend this meeting on one of the most important issues facing our societies: innovation in our education systems.
It is a pleasure to be with you today at this seminar that will debate how to prepare the Spanish economy to face the opportunities and challenges posed by the new production and digital revolution. I am grateful to the Fundación Areces for its kind invitation, and to Minister Alvaro Nadal for joining us.
English, Excel, 8,975kb
Strong Performers and Successful Reformers in Education Guidance from PISA for the Canary Islands, Spain
This book draws on work on green innovation across several parts of the OECD to show how it can drive sustainable growth and job creation. It explores policy actions for the deployment of new technologies and innovations as they emerge.
This book examines dynamics between demand and innovation and provides insights into the rationale and scope for public policies. Drawing on country experience and case studies, it illustrates good practices for designing, implementing and evaluating demand-side innovation policies.
Plan Avanza has created a large-scale information society agenda addressing the need for international and inter-regional convergence in ICT access and use, and greater integration of citizens, businesses and the public administration into the information society.
Plan Avanza is an initiative of the Spanish Government to place Spain in a leading position within the Information and Knowledge Society. As part of its review, the OECD and the Government of Spain hosted an international workshop with policy experts to discuss the preliminary finding
This conference considered innovation in the software sector from an economic perspective, taking into account the factors that drive innovation, including key framework conditions.
Bilingual (English/Spanish) final report on the OECD peer review of Spain’s “policy mix” for research and innovation policies.
This publication examines the innovation system in pharmaceutical biotechnology in eight OECD countries. Based on rich evidence, it draws policy recommendations to foster innovation in biopharmaceuticals advocating an integrated policy approach.